Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 60Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Myelodysplastic Syndromes 52Leukemia 47Leukemia, Myelomonocytic, Chronic 42Leukemia, Lymphocytic, Chronic, B-Cell 38Multiple Myeloma 36Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 35Myeloproliferative Disorders 34Hodgkin Disease 32Lymphoma 31Congenital Abnormalities 31Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Follicular 28Burkitt Lymphoma 28Primary Myelofibrosis 27Lymphoma, Mantle-Cell 25Anemia, Refractory 25Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 24Blast Crisis 22Anemia, Aplastic 19Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Polycythemia Vera 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 16

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × fludarabine phosphate × Classical hematology × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡